SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001628280-23-007900
Filing Date
2023-03-14
Accepted
2023-03-14 17:13:03
Documents
82
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K vyne-20221231.htm   iXBRL 10-K 2117854
2 EX-4.1 exhibit4112312022.htm EX-4.1 24585
3 EX-21.1 exhibit211listofsubsidiari.htm EX-21.1 3696
4 EX-23.1 exhibit231consentus12312022.htm EX-23.1 2363
5 EX-23.2 exhibit232consentpwc123120.htm EX-23.2 2148
6 EX-31.1 vyne-20221231xexx311.htm EX-31.1 10830
7 EX-31.2 vyne-20221231xexx312.htm EX-31.2 10824
8 EX-32.1 vyne-20221231xexx321.htm EX-32.1 6986
9 EX-32.2 vyne-20221231xexx322.htm EX-32.2 6953
15 vyne-20221231_g1.jpg GRAPHIC 36706
  Complete submission text file 0001628280-23-007900.txt   8596699

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vyne-20221231.xsd EX-101.SCH 52194
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vyne-20221231_cal.xml EX-101.CAL 73583
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vyne-20221231_def.xml EX-101.DEF 344348
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vyne-20221231_lab.xml EX-101.LAB 701688
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vyne-20221231_pre.xml EX-101.PRE 502070
76 EXTRACTED XBRL INSTANCE DOCUMENT vyne-20221231_htm.xml XML 1063367
Mailing Address 685 ROUTE 202/206, SUITE 301A BRIDGEWATER NJ 08807
Business Address 685 ROUTE 202/206, SUITE 301A BRIDGEWATER NJ 08807 800-775-7936
VYNE Therapeutics Inc. (Filer) CIK: 0001566044 (see all company filings)

IRS No.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38356 | Film No.: 23731974
SIC: 2834 Pharmaceutical Preparations